Jump to ContentJump to Main Navigation

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Tate, Jillian R. / Tsongalis, Gregory J.

12 Issues per year


IMPACT FACTOR 2014: 2.707
Rank 6 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2014: 0.741
Source Normalized Impact per Paper (SNIP) 2014: 1.011
Impact per Publication (IPP) 2014: 2.310

VolumeIssuePage

Issues

“Coelionomics”: towards understanding the molecular pathology of coeliac disease

Begoña Diosdado1 / Erica van Oort2 / Cisca Wijmenga3

1.

2.

3.

Corresponding author: Prof. Cisca Wijmenga, Complex Genetics Section, Department of Biomedical Genetics, Stratenum 2.117, University Medical Centre Utrecht, P.O. Box 85060 AT, 3508 AB Utrecht, The Netherlands Phone: +31-30 253 8427, Fax: +31-30 253 8479,

Citation Information: Clinical Chemical Laboratory Medicine. Volume 43, Issue 7, Pages 685–695, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2005.117, August 2005

Publication History

Received:
January 13, 2005
Accepted:
May 19, 2005
Published Online:
2005-08-22

Abstract

Coeliac disease (CD) is an inflammatory disorder of the small intestine characterised by a permanent intolerance to gluten-derived peptides. When gluten-derived peptides reach the lamina propria in CD patients, they provoke specific changes in the mucosa of their small intestine. Although the susceptibility to CD is strongly determined by environmental gluten, it is clearly a common genetic disorder. Important genetic factors for CD are the HLA-DQ genes located in the MHC region on chromosome 6 [ HLA-DQ2 (95%) or HLA-DQ8 (∼5%) heterodimers]. So far, the only treatment for CD consists of a life-long gluten-free diet. A key question in CD is why the gluten-derived peptides are resistant to further breakdown by endogenous proteases and how, in turn, they can activate a harmful immune response in the lamina propria of genetically predisposed individuals. Four mechanisms, namely apoptosis, oxidative stress, matrix metalloproteinases and dysregulation of proliferation and differentiation, are thought to play a role in the pathophysiology of CD. Whether the genes involved in these four mechanisms play a causative role in the development of the villous atrophy or are, in fact, a consequence of the disease process is unknown. In this review we summarise these mechanisms and discuss their validity in the context of current insights derived from genetic, genomic and molecular studies. We also discuss future directions for research and the therapeutic implications for patients.

Keywords: apoptosis; coeliac disease; matrix metalloproteinases; oxidative stress; proliferation and differentiation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Paolo Bergamo, Gianna Palmieri, Ennio Cocca, Ida Ferrandino, Marta Gogliettino, Antonio Monaco, Francesco Maurano, and Mauro Rossi
European Journal of Nutrition, 2015
[2]
Amelia Barilli, Bianca Maria Rotoli, Rossana Visigalli, and Valeria Dall'Asta
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014, Volume 1842, Number 9, Page 1364
[3]
Kirsty Brown, Daniella DeCoffe, Erin Molcan, and Deanna L. Gibson
Nutrients, 2012, Volume 4, Number 12, Page 1095
[4]
Anne I. Lahdenperä, Karin Fälth-Magnusson, Lotta Högberg, Johnny Ludvigsson, and Outi Vaarala
Scandinavian Journal of Gastroenterology, 2014, Volume 49, Number 2, Page 145
[5]
Marzia Dolcino, Giovanna Zanoni, Caterina Bason, Elisa Tinazzi, Elisa Boccola, Enrico Valletta, Giovanna Contreas, Claudio Lunardi, and Antonio Puccetti
Immunologic Research, 2013, Volume 56, Number 2-3, Page 465
[6]
M. P. M. Adriaanse, G. J. Tack, V. Lima Passos, J. G. M. C. Damoiseaux, M. W. J. Schreurs, K. van Wijck, R. G. Riedl, A. A. M. Masclee, W. A. Buurman, C. J. J. Mulder, and A. C. E. Vreugdenhil
Alimentary Pharmacology & Therapeutics, 2013, Volume 37, Number 4, Page 482
[7]
Gianna Ferretti, Tiziana Bacchetti, Letizia Saturni, Nicola Manzella, Cinzia Candelaresi, Antonio Benedetti, and Antonio Di Sario
Journal of Lipids, 2012, Volume 2012, Page 1
[8]
Paolo Bergamo, Marta Gogliettino, Gianna Palmieri, Ennio Cocca, Francesco Maurano, Rosita Stefanile, Marco Balestrieri, Giuseppe Mazzarella, Chella David, and Mauro Rossi
Molecular Nutrition & Food Research, 2011, Volume 55, Number S2, Page S248
[9]
Inger Brandt, Simon Scharpé, and Anne-Marie Lambeir
Clinica Chimica Acta, 2007, Volume 377, Number 1-2, Page 50
[10]
K. Mollazadegan, M. Kugelberg, B. E. Lindblad, and J. F. Ludvigsson
American Journal of Epidemiology, 2011, Volume 174, Number 2, Page 195
[11]
Gianfranco Mamone, Gianluca Picariello, Francesco Addeo, and Pasquale Ferranti
Expert Review of Proteomics, 2011, Volume 8, Number 1, Page 95
[12]
Amanda J. MacFarlane and Patrick J. Stover
Nutrition Reviews, 2008, Volume 65, Page S157
[13]
K. Juuti-Uusitalo, M. Mäki, H. Kainulainen, J. Isola, and K. Kaukinen
Clinical & Experimental Immunology, 2007, Volume 150, Number 2, Page 294
[14]
D. Sánchez, L. Palová-Jelínková, J. Felsberg, M. Šimšová, A. Pekáriková, B. Pecharová, I. Swoboda, T. Mothes, C. J. J. Mulder, Z. Beneš, H. Tlaskalová-Hogenová, and L. Tučková
Clinical & Experimental Immunology, 2008, Volume 153, Number 3, Page 351

Comments (0)

Please log in or register to comment.